Therefore, this connection promotes the glycolytic phenotype of cancer cells, that are either deficient in p53 or exposed to hypoxia, and the ablation of CD44 results in marked depletion of cellular reduced glutathione (GSH) and an increased intracellular level of reactive oxygen species (ROS) in cancer cells [13]. The gene discussed is CD44; the disease is cancer.